Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey
Nyfors, A.
Danish Medical Bulletin 27(2): 74-96
1980
ISSN/ISBN: 0907-8916 PMID: 7000451 Document Number: 159822
Document emailed within 1 workday
Related Documents
Schmähl, D. 1971: Side-effects of cytostatic therapy with special reference to potential carcinogenic effects Der Internist 12: Suppl. 1: 115-9Barnardo, D.; Almeyda, J.; Baker, H.; Landells, J.; Levene, G. 1971: Hepatic structure and function in psoriasis before and after treatment with methotrexate Gut 12(10): 863
Smith, K.C. 2000: Systemic therapy of psoriasis using methotrexate Skin Therapy Letter 6(3): 1-2; 5
Kozub, P.; Simaljakova, M. 2011: Systemic therapy of psoriasis: methotrexate Bratislavske Lekarske Listy 112(7): 390-394
Kaur, S.; Kaur, I.; Bhushnurmath, S.R.; Kumar, B. 1986: Methotrexate Therapy For Psoriasis(A Preliminary Report) Indian Journal of Dermatology Venereology and Leprology 52(3): 155-157
Verdich, J.; Christensen, A.L. 1979: Pulmonary disease complicating intermittent methotrexate therapy of psoriasis Acta Dermato-Venereologica 59(5): 471-473
Talwar, S.; Tiwari, V.D.; Lakhtakia, R.; Panvelkar, V. 1995: Sequential clinico-histological studies in psoriasis following methotrexate therapy Indian Journal of Dermatology Venereology and Leprology 61(5): 284-287
Pander Maat, H.; Klaassen, R. 1996: The effect of the wording of information about side effects on patients' interpretation of reported side effects Nederlands Tijdschrift Voor Geneeskunde 140(8): 424-427
Schnabel, A.; Reinhold-Keller, E.; Willmann, V.; Dihlmann, W.; Gross, W.L. 1994: Side effects and efficiency of 15 mg and 25 mg methotrexate per week in chronic polyarthritis Zeitschrift für Rheumatologie 53(3): 142-149
Witty, L.A.; Steiner, F.; Curfman, M.; Webb, D.; Wheat, L.J. 1992: Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis Archives of Dermatology 128(1): 91-93
Zargari, O. 2005: Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis Dermatology Online Journal 11(3): 21
Vlcek, F.; Mikulíková, D. 1995: The effect of methotrexate on activity of T-lymphocyte marker enzymes in patients with psoriasis vulgaris Bratislavske Lekarske Listy 96(3): 137-140
van Dooren-Greebe, R.J.; Kuijpers, A.L.; Termorshuizen, F.; van de Kerkhof, P.C. 1995: Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate Acta Dermato-Venereologica 75(5): 393-396
Moldenhauer, E.; Dabels, J.; Diwok, K.; Leithäuser, W.; Nowotny, P. 1973: Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy Dermatologische Monatschrift 159(3): 242-248
Uchida, J.; Okada, H.; Ohguchi, N.; Kawa, G.; Koyama, Y.; Mikami, O.; Kawamura, H.; Ohhara, T.; Matsuda, T. 1997: Comparison of side effects caused by intra-arterial and intravenous infusion of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) for urothelial cancer Hinyokika Kiyo. Acta Urologica Japonica 43(9): 637-640
Janukowicz, K. 1972: Side effects of antibiotics with particular reference to allergic reactions Wiadomosci Lekarskie 25(5): 419-423
Rongioletti, F.; Burlando, M.; Parodi, A. 2014: Inflammatory/infectious cutaneous side effects of biological drugs in patients with psoriasis: a general review with personal data Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(3): 311-316
Schulze, H.J.; Steigleder, G.K. 1984: Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris Zeitschrift für Hautkrankheiten 59(10): 654-656
Gutnikova, A.R.; Alimov, M.M.; Kasymov, A.K.; Abidova, S.S. 1992: Side effects of hemosorption in the treatment of acute hepatic insufficiency Klinicheskaia Khirurgiia 1: 29-30
Lauria, F.; Baccarani, M.; Fiacchini, M.; Frezza, R.; Gobbi, M.; Tura, S. 1978: 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas Cancer Treatment Reports 62(8): 1193-1197